biote Corp. (NASDAQ:BTMD) Major Shareholder Buys $23,720.04 in Stock

biote Corp. (NASDAQ:BTMD - Get Free Report) major shareholder Guines Llc bought 7,321 shares of the firm's stock in a transaction that occurred on Thursday, April 3rd. The stock was bought at an average cost of $3.24 per share, for a total transaction of $23,720.04. Following the completion of the transaction, the insider now directly owns 4,040,868 shares of the company's stock, valued at approximately $13,092,412.32. The trade was a 0.18 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.

Guines Llc also recently made the following trade(s):

  • On Monday, April 7th, Guines Llc purchased 43,378 shares of biote stock. The shares were bought at an average cost of $3.15 per share, for a total transaction of $136,640.70.
  • On Monday, March 31st, Guines Llc acquired 106,000 shares of biote stock. The shares were bought at an average cost of $3.32 per share, with a total value of $351,920.00.
  • On Monday, March 17th, Guines Llc bought 100 shares of biote stock. The stock was purchased at an average price of $3.74 per share, for a total transaction of $374.00.
  • On Thursday, March 13th, Guines Llc purchased 750,000 shares of biote stock. The shares were purchased at an average price of $3.22 per share, with a total value of $2,415,000.00.

biote Stock Down 1.2 %




biote stock opened at $3.25 on Tuesday. The firm has a market capitalization of $177.81 million, a P/E ratio of 12.50 and a beta of 1.17. The firm has a fifty day moving average of $4.30 and a 200-day moving average of $5.28. biote Corp. has a 52-week low of $3.04 and a 52-week high of $8.44.

Institutional Trading of biote

Large investors have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD acquired a new position in shares of biote during the fourth quarter worth about $67,000. Commonwealth Equity Services LLC acquired a new position in biote during the 4th quarter worth approximately $68,000. Public Employees Retirement System of Ohio purchased a new position in biote in the 4th quarter worth approximately $69,000. Intech Investment Management LLC acquired a new stake in biote in the fourth quarter valued at approximately $71,000. Finally, SG Americas Securities LLC purchased a new stake in shares of biote during the fourth quarter valued at approximately $76,000. 21.68% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Craig Hallum decreased their target price on biote from $12.00 to $8.00 and set a "buy" rating for the company in a report on Thursday, March 13th.

View Our Latest Analysis on BTMD

biote Company Profile

(Get Free Report)

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.

Insider Buying or Selling at biote?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for biote and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles